Alliance for the Prudent Use of Antibiotics
The mission of the Alliance for the Prudent Use of Antibiotics (APUA) is to strengthen global defenses against infectious disease by ensuring access to effective treatment and promoting appropriate antibiotic use to contain drug resistance. With a network of affiliated chapters in 16 countries, APUA stands as the world’s leading organization conducting research and education on antimicrobial treatment and resistance at the grassroots and global levels.
- UN assembly outlines goals for reigning in resistance
- CDC fuels antibiotic resistance research with $14 million; 34 projects funded
- U.S. Food and Agriculture Association (FAO) releases 4-year action plan
- European animal-antibiotic sales data show downward trend
- European farmers battle livestock-associated MRSA
- Norwegian “search and destroy” strategy identifies farm worker import of MRSA
- New variant of LA-MRSA shared by animals and humans
- PEW calls for changes to FDA Guidance for judicious use of antibiotics in animals
- Study finds higher levels of antimicrobial resistance in resource-poor nations
- Antibiotic prescription choices fall seriously short of recommendations
- CDC releases new guidance for outpatient antimicrobial stewardship
- New tool may aid antimicrobial stewardship in pediatric RTIs.
- Rapid diagnostics reduce MRSA transmission in emergency hospital
- Vietnam study shows C-reactive protein testing reduces antibiotic use
- C. difficile infection found to correlate with previous patient on antibiotics
- Hospital laundry and sinks found to harbor superbugs
- Antibacterial peptides found in marsupial milk
- Human gut bacteria secrete antimicrobial
- Antibacterial compounds found in maggots
- Cranberry compounds may help reduce dependence on antibiotics
- Novel agar platform demonstrates microbial evolution
- APUA supports bill to track superbug infections in California
- APUA joins efforts to adopt "Cures/Innovations" package
- Events Calendar
- Amazon Smile!
APUA Newsletter Vol. 34 No. 2
"Evaluating Antibiotic Resistance, Residues and Revitalization"
The Faces of Antibiotic Resistance (FOAR) Project
The Alliance for the Prudent Use of Antibiotics (APUA) is part of the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR). As part of a joint effort with other S-FAR members, we are seeking patients or family members who have experienced a resistant infection, such as MRSA, CRE, etc. who are willing to share their story. These stories are critical to help us demonstrate to policymakers the human cost of and urgent need for efforts to combat antimicrobial resistance to protect patients and public health.
Antibiotic resistant bacteria are responsible for at least 23,000 deaths and at least 2 million infections each year, and cost the healthcare system approximately $20 billion. They also complicate many areas of medicine, including the care of preterm infants, chemotherapy, organ and bone marrow transplants, and other surgeries.
With APUA’s help, S-FAR is planning to publish a collection of stories by people and families directly impacted by an antibiotic resistant infection. If you, or one of your loved ones, patients, colleagues, etc., has suffered from an antimicrobial resistant infection and you or they are willing to share your story for this effort, please contact us at firstname.lastname@example.org by July 31st. We would be happy to work with you to put the story together. Each person telling their story will be given final approval rights before publication.
Thank you for considering this important request.
APUA Voices Support for Global Industry Declaration Tackling Antimicrobial Resistance
The Alliance for the Prudent Use of Antibiotics (APUA) applauds the global pharmaceutical, biotechnology and diagnostics industry declaration on combating antimicrobial resistance.
“Marking a major step in the global battle fighting the problems of antimicrobial resistance, the statement sets out for the first time how governments and industry need to work together to support sustained investment in the new products needed to beat the challenges of rising drug resistance,” said Dr. Stuart B. Levy, CEO of the Alliance for the Prudent Use of Antibiotics.
Launched at the World Economic Forum in Davos, Switzerland, this declaration formally cites the encouraging news of more than 85 international companies and nine industry associations across 18 countries working together to take collective action to address the resistance problem.
APUA Leadership Award - 2015
The Alliance for the Prudent Use of Antibiotics is pleased to honor Kevin Outterson, J.D., LL.M., professor at the Boston University School of Law and Boston University School of Public Health, as the recipient of our 2015 Leadership Award.
Professor Outterson, the N. Pike Scholar in Health and Disability Law and co-director of BU's health law program, is the author of groundbreaking models to address the economic challenge of developing new antibiotics. Together with his scholarship and testimony before the United States Congress, he elevates the issues of antimicrobial resistance to a new level, catalyzing access to effective treatment of bacterial infections for all.
"We recognize Professor Outterson as a thought leader in the worldwide effort to contain antibiotic resistance," said APUA President Stuart B. Levy. "His intellectual commitment to the economic realities of developing new drugs that affect the global aspects and consequences of antibacterial resistance alter our thinking about answers to these complex problems."
Our warmest congratulations to Professor Outterson.
APUA President Levy attends "White House Forum on Antibiotic Stewardship"
The summit, the first of its kind, was attended by 150+ leaders of the health, food, and agriculture industries on June 2, 2015. The event was buttressed by the signing of a Presidential Memorandum that creates Federal preference for meat and poultry that are produced with responsible antibiotic use. The various attendees made commitments to abide by the standards set forth by the recently-publishedNational Action Plan for Combating Antibiotic-Resistance Bacteria. Read APUA's commitment here.
Antibiotics are humanity's key defense against disease-causing microbes. The growing prevalence of antibiotic resistance threatens a future where these drugs can no longer cure infections and killer epidemics run rampant. The Alliance for the Prudent Use of Antibiotics (APUA) has been the leading global non-governmental organization fighting to preserve the effectiveness of antimicrobial drugs since 1981. With affiliated chapters in over 66 developed and developing countries, we conduct research, education and advocacy programs to control antimicrobial resistance and ensure access to effective antibiotics for current and future generations. For more information on antibiotic resistance research, visit our partner lab at the Center for Adaptation Genetics and Drug Resistance.
"Antibiotics are uniquely societal drugs because individual use affects others in the community and environment. Better stewardship, incentives, and establishment of a special regulatory category will improve how they are used, marketed, and developed through incentives to industry."
Stuart B. Levy, M.D.
President of APUA, professor at Tufts University School of Medicine
From the IOM 25th Anniversary Symposium (1996) and The Antibiotic Paradox (2002)
In case you missed it, our latest webinar
is now available for streaming.